Here are the news highlights for the week of June 4th on digital pathology.
Flagship Biosciences acquires IHCtech, a leading provider of research immunohistochemistry and histology services
Flagship Biosciences announces today the acquisition of IHCtech LLC at the Colorado Anschutz Medical Campus. Founded in 2002, IHCtech has developed a strong reputation for high-quality advanced immunohistochemistry procedures, meeting the IHC and histology needs of pharmaceutical and academic investigators. Learn more…
Pathology Visions Abstract Deadline Extended to June 15th
Pathology Visions has extended the deadline for abstract submissions to Friday, June 15, 2012. Submitted abstracts will be reviewed by the Pathology Visions Program Committee and chosen presenters will be provided a conference registration pass (valued at $699), economy class round trip airfare, and lodging expenses for a maximum of 3 nights (October 28 – 31) at the host hotel. Accepted presenters will now be contacted by June 30, 2012.
Click here to submit an abstract
Huron Technologies Launches TISSUEscope™ 4000XT for High Throughput Scanning
Huron Technologies announces the launch of the TISSUEscope™ 4000XT with Autoloader Module for high volume and high throughput scanning. The fully-integrated system offers imaging of small and large glass slides for both brightfield and confocal fluorescent imaging modes and is designed to be compatible with all versions of TISSUEscope™ scanners. Learn more…
PathXL and Olympus Soft Imaging Solutions Announce Digital Pathology Education Partnership
Olympus Soft Imaging Solutions GmbH, a leading system solution provider in microscopy and PathXL Ltd., a company that specialises in developing web-based software for digital pathology, announced today a non-exclusive worldwide original equipment manufacturer (OEM) software distribution agreement for PathXL’s Digital Pathology Education Solutions. Learn more…
Minnesota In The Middle- Part 2 from Tissuepathology.com
The post below I wrote about three years ago and at that time did not mention that the caller was inquiring about my interest and ability to participate in the FDApanel looking at digital pathology back in the Fall of 2009. That panel of course was put together which I have mentioned on prior occasion (see The FDA States, WSI Systems Are Not Class I Exempt (10/23/2009)).
Nothing of significance happened until the FDA was invited to speak at Pathology Visions 2011 which I made a few notes about on a related story earlier this year (see Regulators regulating digital scanners). Since that discussion there appears to be a standoff between manufacturers and the FDA. Read more…
